{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T04:09:56Z","timestamp":1749787796388,"version":"3.41.0"},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"22","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,30]]},"abstract":"<jats:p>Reproductive endocrine diseases (REDs), including polycystic ovary syndrome, endometriosis, and female infertility, are prevalent reproductive disorders that affect a significant number of women worldwide. Recent research has indicated that the inhibitors of proprotein convertase subtilisin\/kexin type 9 (PCSK9) and 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR), in addition to reducing cholesterol levels, may have pleiotropic effects on REDs. However, the impact of PCSK9 and HMCGR inhibitor on REDs is controversial. This study employed drug-target Mendelian randomization to examine the causal relationships between PCSK9\/HMGCR inhibitors and REDs, using established coronary heart disease associations as validation controls. Multiple Mendelian randomization methods, primarily inverse-variance weighted (IVW), were implemented alongside sensitivity analyses to verify result reliability. HMGCR inhibitor demonstrated significant protective effects against polycystic ovary syndrome development (IVW OR 0.321, 95% CI 0.136\u20130.757; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.009). Correspondingly, PCSK9 inhibitor exhibited favorable associations with endometriosis risk reduction (IVW OR 0.971, 0.688\u20130.909; <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.001). These observations remained consistent across all sensitivity evaluations, confirming analytical robustness. Our findings support a causal link between HMGCR\/PCSK9 inhibitors and REDs, suggesting potential therapeutic implications. However, further mechanistic studies are needed to clarify the biological pathways and clinical relevance of these results.<\/jats:p>","DOI":"10.1097\/md.0000000000042685","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:01:04Z","timestamp":1749758464000},"page":"e42685","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Assessing the impact of PCSK9 and HMGCR inhibitor on reproductive endocrine diseases: A drug-target Mendelian randomization analysis"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5984-066X","authenticated-orcid":false,"given":"Na","family":"Aru","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of the Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuntian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiology, West China Hospital, Sichuan University, Chengdu, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8237-8813","authenticated-orcid":false,"given":"Jiaming","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Urology, West China Hospital, Sichuan University, Chengdu, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250612","doi-asserted-by":"crossref","first-page":"115470","DOI":"10.1016\/j.biopha.2023.115470","article-title":"The role of macrophages in polycystic ovarian syndrome and its typical pathological features: a narrative review.","volume":"167","author":"Feng","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1002\/ijgo.15031","article-title":"Women\u2019s experience of polycystic ovary syndrome management: a systematic review and meta-synthesis.","volume":"164","author":"Guan","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"R3-20250612","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1042\/CS20220146","article-title":"Assessing hypothalamic pituitary gonadal function in reproductive disorders.","volume":"137","author":"Koysombat","year":"2023","journal-title":"Clin Sci (Lond)"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"1245719","DOI":"10.3389\/fendo.2023.1245719","article-title":"Trends in metabolic dysfunction in polycystic ovary syndrome: a bibliometric analysis.","volume":"14","author":"Xu","year":"2023","journal-title":"Front Endocrinol"},{"key":"R5-20250612","first-page":"89","article-title":"Polycystic ovary syndrome and metabolic disorders: a review of the literature.","volume":"26","author":"Ali","year":"2022","journal-title":"Afr J Reprod Health"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"117563","DOI":"10.1016\/j.cca.2023.117563","article-title":"Biomarkers of endometriosis.","volume":"549","author":"Pant","year":"2023","journal-title":"Clin Chim Acta"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00404-023-07205-3","article-title":"\u201cThe sound of silence\u201d Giving voice to endometriosis-related positional dyspareunia.","volume":"309","author":"Merli","year":"2024","journal-title":"Arch Gynecol Obstet"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"102709","DOI":"10.1016\/j.nano.2023.102709","article-title":"State-of-the-art and future perspectives in infertility diagnosis: conventional versus nanotechnology-based assays.","volume":"54","author":"Andone","year":"2023","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"R9-20250612","first-page":"1490","article-title":"The silent threat to women\u2019s fertility: uncovering the devastating effects of oxidative stress.","volume":"12","author":"Kaltsas","year":"2023","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"R10-20250612","doi-asserted-by":"crossref","first-page":"1219045","DOI":"10.3389\/fphys.2023.1219045","article-title":"Fertility loss: negative effects of environmental toxicants on oogenesis.","volume":"14","author":"Yao","year":"2023","journal-title":"Front Physiol"},{"key":"R11-20250612","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/REP-14-0499","article-title":"Pathogenesis of polycystic ovary syndrome: multifactorial assessment from the foetal stage to menopause.","volume":"150","author":"de Melo","year":"2015","journal-title":"Reproduction (Cambridge, England)"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"e15230","DOI":"10.1111\/dme.15230","article-title":"The impact of diabetes and obesity on fertility and the potential role of gut hormones as treatment.","volume":"40","author":"Sridhar","year":"2023","journal-title":"Diabet Med"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.3390\/nu15163582","article-title":"Low-calorie ketogenic diet: potential application in the treatment of polycystic ovary syndrome in adolescents.","volume":"15","author":"Calcaterra","year":"2023","journal-title":"Nutrients"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/jc.2006-2002","article-title":"Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls.","volume":"92","author":"McCartney","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bpobgyn.2017.08.008","article-title":"Polycystic ovary syndrome in adolescents.","volume":"48","author":"Rothenberg","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2014.12.017","article-title":"On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effects.","volume":"238","author":"Tavori","year":"2015","journal-title":"Atherosclerosis"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"110649","DOI":"10.1016\/j.clinbiochem.2023.110649","article-title":"Treatment target achievement in patients with familial hypercholesterolemia: a real-world descriptive study.","volume":"120","author":"Faubert","year":"2023","journal-title":"Clin Biochem"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"102081","DOI":"10.1016\/j.cpcardiol.2023.102081","article-title":"Cholesterol homeostasis, mechanisms of molecular pathways, and cardiac health: a current outlook.","volume":"49","author":"Kumar","year":"2023","journal-title":"Curr Probl Cardiol"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jcmgh.2023.09.001","article-title":"Assessing the impact of PCSK9 and HMGCR inhibition on liver function: drug-target Mendelian randomization analyses in 4 ancestries.","volume":"17","author":"Rosoff","year":"2024","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R20-20250612","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.5114\/aoms\/158546","article-title":"The effects of statins on the function and differentiation of blood cells.","volume":"19","author":"Chamani","year":"2023","journal-title":"Arch Med Sci"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.fertnstert.2004.03.037","article-title":"Mevastatin inhibits ovarian theca-interstitial cell proliferation and steroidogenesis.","volume":"82","author":"Izquierdo","year":"2004","journal-title":"Fertil Steril"},{"key":"R22-20250612","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.fertnstert.2005.09.030","article-title":"Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trial.","volume":"85","author":"Duleba","year":"2006","journal-title":"Fertil Steril"},{"key":"R23-20250612","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1210\/jc.2006-1988","article-title":"Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: prospective, randomized, crossover trial.","volume":"92","author":"Banaszewska","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R24-20250612","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EC-17-0217","article-title":"The effect of atorvastatin on pancreatic beta cell requirement in women with polycystic ovary syndrome.","volume":"6","author":"Sathyapalan","year":"2017","journal-title":"Endocrine Connections"},{"key":"R25-20250612","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.fertnstert.2008.06.006","article-title":"Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study.","volume":"92","author":"Kaya","year":"2009","journal-title":"Fertil Steril"},{"key":"R26-20250612","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1016\/j.fertnstert.2009.08.043","article-title":"Unfavorable lipid profile in women with endometriosis.","volume":"93","author":"Melo","year":"2010","journal-title":"Fertil Steril"},{"key":"R27-20250612","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/14647273.2021.1919764","article-title":"Role of endometriosis in defining cardiovascular risk: a gender medicine approach for women\u2019s health.","volume":"25","author":"Cirillo","year":"2022","journal-title":"Hum Fertil (Camb)"},{"key":"R28-20250612","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/HYPERTENSIONAHA.117.09056","article-title":"Association between endometriosis and hypercholesterolemia or hypertension.","volume":"70","author":"Mu","year":"2017","journal-title":"Hypertension"},{"key":"R29-20250612","doi-asserted-by":"crossref","first-page":"e032321","DOI":"10.1136\/bmjopen-2019-032321","article-title":"Experiences of health after dietary changes in endometriosis: a qualitative interview study.","volume":"10","author":"Vennberg Karlsson","year":"2020","journal-title":"BMJ open"},{"key":"R30-20250612","doi-asserted-by":"crossref","first-page":"E391","DOI":"10.1503\/cmaj.160744","article-title":"Failure of fertility therapy and subsequent adverse cardiovascular events.","volume":"189","author":"Udell","year":"2017","journal-title":"CMAJ"},{"key":"R31-20250612","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jacc.2022.05.041","article-title":"Mendelian randomization study of PCSK9 and HMG-CoA reductase inhibition and cognitive function.","volume":"80","author":"Rosoff","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R32-20250612","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization.","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"R33-20250612","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease.","volume":"365","author":"Nicholls","year":"2011","journal-title":"N Engl J Med"},{"key":"R34-20250612","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"R35-20250612","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. cholesterol and recurrent events trial investigators.","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"R36-20250612","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"R37-20250612","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary prevention study group.","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"R38-20250612","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.phrs.2014.02.009","article-title":"Cardiovascular effects of statins, beyond lipid-lowering properties.","volume":"88","author":"Mihos","year":"2014","journal-title":"Pharmacol Res"},{"key":"R39-20250612","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jacc.2010.07.037","article-title":"Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans.","volume":"57","author":"Liuni","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R40-20250612","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jacc.2009.11.046","article-title":"Rosuvastatin prevents conduit artery endothelial dysfunction induced by ischemia and reperfusion by a cyclooxygenase-2-dependent mechanism.","volume":"55","author":"Liuni","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"R41-20250612","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.jacc.2007.02.051","article-title":"Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin: effect of combination with oral L-arginine.","volume":"49","author":"B\u00f6ger","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R42-20250612","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11910-022-01197-4","article-title":"Lipid-modifying therapies and stroke prevention.","volume":"22","author":"Hackam","year":"2022","journal-title":"Curr Neurol Neurosci Rep"},{"key":"R43-20250612","doi-asserted-by":"crossref","first-page":"173114","DOI":"10.1016\/j.ejphar.2020.173114","article-title":"Statins and PCSK9 inhibitors: a new lipid-lowering therapy.","volume":"878","author":"Gallego-Colon","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"R44-20250612","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/cvr\/cvz313","article-title":"PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1.","volume":"116","author":"Ding","year":"2020","journal-title":"Cardiovasc Res"},{"key":"R45-20250612","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.120.046290","article-title":"PCSK9 (Proprotein Convertase Subtilisin\/Kexin 9) enhances platelet activation, thrombosis, and myocardial infarct expansion by binding to platelet CD36.","volume":"143","author":"Qi","year":"2021","journal-title":"Circulation"},{"key":"R46-20250612","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-020-2911-7","article-title":"Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer.","volume":"588","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"R47-20250612","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.tem.2023.08.005","article-title":"Questioning PCOS phenotypes for reclassification and tailored therapy.","volume":"34","author":"Myers","year":"2023","journal-title":"Trends Endocrinol Metab"},{"key":"R48-20250612","doi-asserted-by":"crossref","first-page":"108284","DOI":"10.1016\/j.pharmthera.2022.108284","article-title":"Targeting adipokines in polycystic ovary syndrome and related metabolic disorders: from experimental insights to clinical studies.","volume":"240","author":"Xu","year":"2022","journal-title":"Pharmacol Ther"},{"key":"R49-20250612","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tem.2023.02.002","article-title":"Gonadotropins as pharmacological agents in assisted reproductive technology and polycystic ovary syndrome.","volume":"34","author":"Singh","year":"2023","journal-title":"Trends Endocrinol Metab"},{"key":"R50-20250612","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tig.2022.01.005","article-title":"Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges.","volume":"38","author":"Wang","year":"2022","journal-title":"Trends Genet"},{"key":"R51-20250612","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1210\/en.2019-00588","article-title":"Inflammatory stimuli trigger increased androgen production and shifts in gene expression in theca-interstitial cells.","volume":"160","author":"Fox","year":"2019","journal-title":"Endocrinology"},{"key":"R52-20250612","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/ATVBAHA.113.301301","article-title":"Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.","volume":"34","author":"Chen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R53-20250612","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/ndt\/gfu203","article-title":"Inflammatory stress reduces the effectiveness of statins in the kidney by disrupting HMGCoA reductase feedback regulation.","volume":"29","author":"Chen","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R54-20250612","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.fertnstert.2011.08.010","article-title":"Resveratrol inhibits the mevalonate pathway and potentiates the antiproliferative effects of simvastatin in rat theca-interstitial cells.","volume":"96","author":"Wong","year":"2011","journal-title":"Fertil Steril"},{"key":"R55-20250612","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/jc.2008-1750","article-title":"The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study.","volume":"94","author":"Sathyapalan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R56-20250612","first-page":"CD008565","article-title":"Statins for women with polycystic ovary syndrome not actively trying to conceive.","volume":"10","author":"Raval","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"R57-20250612","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1210\/endo-124-5-2297","article-title":"Mevinolin (lovastatin) inhibits androstenedione production by porcine ovarian theca cells at the level of the 17 alpha-hydroxylase:C-17,20-lyase complex.","volume":"124","author":"Engelhardt","year":"1989","journal-title":"Endocrinology"},{"key":"R58-20250612","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1210\/jc.2010-0770","article-title":"Statins inhibit growth of human theca-interstitial cells in PCOS and non-PCOS tissues independently of cholesterol availability.","volume":"95","author":"Sokalska","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R59-20250612","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/09513590.2017.1418853","article-title":"Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome.","volume":"34","author":"Seyam","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"R60-20250612","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1210\/jc.2013-2674","article-title":"Statin therapy worsens insulin sensitivity in women with polycystic ovary syndrome (PCOS): a prospective, randomized, double-blind, placebo-controlled study.","volume":"98","author":"Puurunen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"R61-20250612","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/jog.15301","article-title":"Effect of statins combined or not combined with metformin on polycystic ovary syndrome: a systematic review and meta-analysis.","volume":"48","author":"Miao","year":"2022","journal-title":"J Obstet Gynaecol Res"},{"key":"R62-20250612","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1210\/en.2016-1092","article-title":"High-fat diet promotion of endometriosis in an immunocompetent mouse model is associated with altered peripheral and ectopic lesion redox and inflammatory status.","volume":"157","author":"Heard","year":"2016","journal-title":"Endocrinology"},{"key":"R63-20250612","doi-asserted-by":"crossref","first-page":"775677","DOI":"10.3389\/fendo.2021.775677","article-title":"Triglyceride-rich lipoproteins and glycoprotein a and b assessed by 1h-nmr in metabolic-associated fatty liver disease.","volume":"12","author":"Moreno-Vedia","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R64-20250612","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1210\/clinem\/dgad376","article-title":"Circulating inflammatory cytokines and female reproductive diseases: a mendelian randomization analysis.","volume":"108","author":"Lin","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R65-20250612","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jacc.2007.10.038","article-title":"Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial.","volume":"51","author":"Miller","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"R66-20250612","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s42003-022-03914-8","article-title":"Paternal low protein diet perturbs inter-generational metabolic homeostasis in a tissue-specific manner in mice.","volume":"5","author":"Morgan","year":"2022","journal-title":"Commun Biol"},{"key":"R67-20250612","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10557-016-6640-y","article-title":"Mendelian randomization for the identification of causal pathways in atherosclerotic vascular disease.","volume":"30","author":"Jansen","year":"2016","journal-title":"Cardiovasc Drugs Ther"},{"key":"R68-20250612","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.rbmo.2022.04.013","article-title":"Association between preconception serum lipid concentrations and treatment outcomes in women with PCOS who underwent ovulation induction.","volume":"45","author":"Cai","year":"2022","journal-title":"Reprod Biomed Online"},{"key":"R69-20250612","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.3390\/nu15143130","article-title":"The association between circulating lipids and female infertility risk: a univariable and multivariable mendelian randomization analysis.","volume":"15","author":"Zhu","year":"2023","journal-title":"Nutrients"},{"key":"R70-20250612","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.3390\/nu14194042","article-title":"Insights into modifiable risk factors of infertility: a mendelian randomization study.","volume":"14","author":"Xu","year":"2022","journal-title":"Nutrients"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T20:01:14Z","timestamp":1749758474000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":70,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042685","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]}}}